Episode Details

In this episode of Global Economic Press, Alex Brady explores the significant contributions of TeamBest Global Companies in the field of nuclear medicine and cancer therapy. Celebrating 16 years of cyclotron innovation, TeamBest Global has been at the forefront of advancing theranostics, which combines therapy and diagnostics to transform cancer treatment. The episode highlights the pivotal role of Best Advanced Biomedical Technologies and Best Cyclotron Systems, under the leadership of Krishnan Suthanthiran, in driving major milestones in diagnostic imaging and targeted therapies. These innovations have facilitated the global expansion of life-saving technologies, making advanced healthcare more accessible.

Best Cyclotron Systems has been instrumental in designing and building high-performance cyclotrons, ranging from 1 Mega Electron Volt to 70 Mega Electron Volt, to produce vital radioisotopes for diagnostic and therapeutic purposes. Notable achievements include the commissioning of the B70 cyclotron in Italy and the development of the BG-95 and B-11 cyclotrons for on-site production of Positron Emission Tomography tracers. TeamBest Global's technology portfolio has led to numerous cyclotron orders and facility expansions across North America, Europe, and India. Their innovations, such as alpha cyclotrons, have the potential to revolutionize theranostics, further solidifying TeamBest's leadership in cancer diagnosis and treatment technologies. For more information about TeamBest Global, please visit www.teambest.com.